Lagis Enterprise Co., Ltd. (TPEX:6730)
35.50
0.00 (0.00%)
May 29, 2026, 12:46 PM CST
Lagis Enterprise Revenue
Lagis Enterprise had revenue of 114.56M TWD in the quarter ending March 31, 2026, a decrease of -0.99%. This brings the company's revenue in the last twelve months to 486.50M, up 6.55% year-over-year. In the year 2025, Lagis Enterprise had annual revenue of 487.65M with 7.33% growth.
Revenue (ttm)
486.50M
Revenue Growth
+6.55%
P/S Ratio
2.65
Revenue / Employee
n/a
Employees
202
Market Cap
1.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 487.65M | 33.29M | 7.33% |
| Dec 31, 2024 | 454.36M | -5.58M | -1.21% |
| Dec 31, 2023 | 459.93M | 17.75M | 4.01% |
| Dec 31, 2022 | 442.19M | 49.15M | 12.50% |
| Dec 31, 2021 | 393.04M | 73.68M | 23.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BenQ Medical Technology | 5.35B |
| Nang Kuang Pharmaceutical | 2.11B |
| Chi Sheng Pharma & Biotech | 1.41B |
| ICARES Medicus | 1.13B |
| Concord Medical | 964.35M |
| Crystalvue Medical | 912.86M |
| Maxigen Biotech | 825.25M |
| Perfect Medical Industry | 779.02M |